Novartis drug VotubiaR recommended by CHMP for EU approval to treat ... Reuters Basel, September 21, 2012 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion for Votubia R (everolimus) tablets* for the treatment of adult patients with renal angiomyolipoma ... Novartis Reports CHMP Adopts Positive Opinion For Votubia For EU Approval Novartis drug Votubia recommended by CHMP Novartis (NVS) Receives Positive EMA CHMP Opinion for Votubia as Kidney ... |
